ArticlesEnvironmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Introduction
Multiple sclerosis is the most common demyelinating disease in high-income countries1 and, according to a report by the Multiple Sclerosis International Federation,2 the global median prevalence of multiple sclerosis has increased from 30 per 100 000 in 2008 to 33 per 100 000 in 2013. Prevalence varies considerably between countries3, 4 and is highest in North America (140 per 100 000) and Europe (108 per 100 000) and lowest in sub-Saharan Africa (2·1 per 100 000) and east Asia (2·2 per 100 000).2 The cause of multiple sclerosis is multifactorial; both genetic and environmental factors contribute to disease risk. In particular, several environmental risk factors, such as Epstein-Barr virus infection,5 smoking,6 and latitude,7 have been proposed; however, the causes of multiple sclerosis are still largely unknown and there are at present no well-established risk factors to assist disease prevention.8
Numerous meta-analyses and systematic reviews for environmental risk factors associated with multiple sclerosis have been published. However, to our knowledge, there has been no effort to summarise the evidence from these meta-analyses and their associated limitations, such as the presence of diverse biases. We did the first umbrella review of the evidence across existing systematic reviews and meta-analyses of observational studies, to provide an overview of the range and validity of the reported associations of diverse environmental risk factors with multiple sclerosis. We summarise the risk factors that have been associated with multiple sclerosis in meta-analyses, assess whether there is evidence for diverse biases in these meta-analyses, and finally assess which of the previously studied associations that have been synthesised in meta-analyses have robust evidence.
Section snippets
Search strategy and eligibility criteria
We did an umbrella review (a systematic collection and assessment of multiple systematic reviews and meta-analyses done on a specific research topic).9 We systematically searched PubMed from inception to Nov 22, 2014 to identify systematic reviews and meta-analyses of observational studies examining associations between environmental (non-genetic) factors and multiple sclerosis. The search strategy used the keywords “multiple sclerosis” AND (“systematic review” OR “meta-analysis”). The full
Results
Overall, 609 articles were searched and 20 articles were deemed eligible (figure). 17 of the 20 eligible articles had a quantitative synthesis providing a summary estimate. 13 of 33 articles screened at full text were excluded because a larger meta-analysis that examined the same risk factors and population was found. These articles pertained to chronic cerebrospinal venous insufficiency,28, 29 Epstein-Barr virus infection30 and seronegativity,31 hepatitis B vaccination,32, 33 immunisations,34
Discussion
We provide an overview and appraisal of environmental risk factors that have been associated with multiple sclerosis. Overall, 44 risk factors have been studied for an association with the disease, including infections and vaccinations, comorbid diseases, surgeries, traumatic events and accidents, exposure to toxic environmental agents, and biochemical biomarkers. Only three of these risk factors (anti-EBNA IgG seropositivity, infectious mononucleosis, and smoking) were supported by evidence
References (79)
Infectious causes of multiple sclerosis
Lancet Neurol
(2005)- et al.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Lancet Neurol
(2010) - et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) Clarifications on the application and interpretation of the test for excess significance and its extensions
J Math Psychol
(2013)- et al.
Physical trauma and risk of multiple sclerosis: a systematic review and meta-analysis of observational studies
J Neurol Sci
(2014) - et al.
Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis
Neurosci Lett
(2014) - et al.
Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis
J Clin Neurosci
(2011) - et al.
Multiple sclerosis
Lancet
(2008) - et al.
Individual and joint action of environmental factors and risk of MS
Neurol Clin
(2011) - et al.
Is there a causal link between hepatitis B vaccination and multiple sclerosis?
Vaccine
(2000)
School-based hepatitis B vaccination programme and adolescent multiple sclerosis
Lancet
Atlas of MS 2013: mapping multiple sclerosis around the world
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
BMC Neurol
Incidence and prevalence of multiple sclerosis in the Americas: a systematic review
Neuroepidemiology
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis
PLoS One
Smoking and multiple sclerosis: an updated meta-analysis
PLoS One
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
J Neurol Neurosurg Psychiatry
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
CMAJ
Quantitative synthesis in systematic reviews
Ann Intern Med
A re-evaluation of random-effects meta-analysis
J R Stat Soc Ser A
Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified
Int J Epidemiol
A simple method for converting an odds ratio to effect size for use in meta-analysis
Stat Med
The combination of estimates from different experiments
Biometrics
Quantifying heterogeneity in a meta-analysis
Stat Med
Uncertainty in heterogeneity estimates in meta-analyses
BMJ
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
BMJ
Bias in meta-analysis detected by a simple, graphical test
BMJ
An exploratory test for an excess of significant findings
Clin Trials
On power and sample size for studying features of the relative odds of disease
Am J Epidemiol
Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis
Mult Scler
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis
Mult Scler
Serum uric acid levels in patients with multiple sclerosis: a meta-analysis
Neurol Res
The false-positive to false-negative ratio in epidemiologic studies
Epidemiology
Revised standards for statistical evidence
Proc Natl Acad Sci USA
Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis
CMAJ
Meta-analysis of the correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis
Vasc Endovasc Surg
Epstein-Barr virus and multiple sclerosis
Epidemiology
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis
Mult Scler
Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review
J Viral Hepat
Cited by (495)
Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review
2024, Multiple Sclerosis and Related DisordersEfficacy of preventive interventions against ventilator-associated pneumonia in critically ill patients: an umbrella review of meta-analyses
2024, Journal of Hospital InfectionUmbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2024, Journal of the American Academy of Child and Adolescent PsychiatryExclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A population registry-based case-control study
2024, Multiple Sclerosis and Related DisordersEpidemiology, epigenetics, and etiological factors in multiple sclerosis
2024, Clinical Aspects of Multiple Sclerosis Essentials and Current Updates